Glypican-3-Targeted 227Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma.
Labadie KP, Hamlin DK, Kenoyer A, Daniel SK, Utria AF, Ludwig AD, Kenerson HL, Li L, Sham JG, Chen DL, Orozco JJ, Yeung RS, Orvig C, Li Y, Wilbur DS, Park JO.
Labadie KP, et al. Among authors: yeung rs.
J Nucl Med. 2022 Jul;63(7):1033-1038. doi: 10.2967/jnumed.121.262562. Epub 2021 Nov 12.
J Nucl Med. 2022.
PMID: 34772791
Free PMC article.